- Home
- AXIL vs KZR Comparison
AXIL vs KZR Comparison
Compare AXIL & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AXIL | KZR |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.4M | 44.5M |
| IPO Year | 2017 | 2018 |
Fundamental Metrics
Financial Performance| Metric | AXIL | KZR |
|---|---|---|
| Price | $7.33 | $7.09 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 8.4K | ★ 49.1K |
| Earning Date | 04-20-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $26,257,522.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $52.38 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.04 | $3.53 |
| 52 Week High | $10.25 | $7.20 |
Technical Indicators
Market Signals| Indicator | AXIL | KZR |
|---|---|---|
| Relative Strength Index (RSI) | 52.87 | 79.00 |
| Support Level | $4.76 | $6.06 |
| Resistance Level | $7.02 | N/A |
| Average True Range (ATR) | 0.51 | 0.21 |
| MACD | 0.13 | 0.06 |
| Stochastic Oscillator | 70.97 | 93.14 |
Price Performance
Historical ComparisonAbout AXIL AXIL Brands Inc.
AXIL Brands Inc is a company which is is a manufacturer and marketer of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, and outdoor speakers, under the AXIL brand. AXIL delivers top hearing enhancement, protection, & audio devices. From ultra comfortable fitting processes, to stereo quality sound performance, to reliable & durable engineering. The company operates two operating segments: hearing enhancement and protection, and hair and skin care.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.